METLIFE INC (MET) stock intrinsic value fair value estimate & owner earnings analysis

MetLife is one of the world's largest life and benefits insurers. Its earnings come from Group Benefits (life, dental, disability and voluntary coverage sold through U.S. employers), Retirement and Income Solutions (pension risk transfer, structured settlements and institutional annuities), Asia (mainly Japan and Korea), Latin America (mainly Mexico and Chile), EMEA, and MetLife Investment Management, which on December 30, 2025 bought the asset manager PineBridge Investments for $885 million in cash. Almost all of its profit is the spread between what its roughly half-trillion-dollar bond, mortgage and private-credit portfolio earns and what it has promised policyholders, plus underwriting margin on group coverage. How we measured earnings. We start from net income, add back true non-cash items (depreciation, investment gains and losses, accrual-versus-cash timing on private-equity holdings) and subtract stock compensation. We do not count interest credited to policyholder accounts or the growth in reserves as owner cash, because that money belongs to policyholders, and we do not add back derivative losses, because the real cash cost of MetLife's hedging program shows up every year in its investing cash flows. Capital spending is not separately disclosed and is immaterial. On this basis MetLife earned between $1.8 billion (2021, distorted by private-equity marks that ran far ahead of cash) and $6.1 billion (2024) a year since the 2017 Brighthouse spin-off, with a median of about $4.9 billion across 2017-2025, which spans a rate cycle, the 2020 shutdown and the 2022 rate shock. Because MetLife has retired roughly 40% of its shares since 2017, that same $4.9 billion spread over today's roughly 647 million diluted shares is about $7.60 a share, which is our starting level. Preferred dividends of about $190 million a year rank ahead of the common and are deducted. In 2025 earnings on this basis were about $4.1 billion, down from $6.1 billion in 2024; the company's own segment reconciliation shows underlying segment earnings rose that year and the drop came from investment, derivative and hedge marks, so we treat 2025 as within the normal range rather than a new lower level. As an insurer, borrowing is part of the business, so we value earnings after interest and subtract no debt; leverage is charged in the bear case instead. Base case: the business earns about $4.9 billion in year one, then grows about 1.5% a year for a decade, roughly the pace at which group benefits premiums and fee-based asset management have grown alongside wages and employment, and then holds flat. We credit no further growth from pension risk transfer, where premium volume has risen sharply but segment earnings have been roughly flat for three years, and none from new markets or margin improvement. Buybacks are not counted as extra growth because they are paid for out of the same earnings we are already valuing. The business is worth about $135 a share; there is no separate debt subtraction for an insurer, so that is also the value to shareholders. Bear case: one full credit cycle of the kind life insurers went through in 2008-2010. In that episode MetLife's own investment losses and derivative and reserve charges wiped out most of two years of earnings and it sold new shares in late 2008 at depressed prices to shore up capital. We model year one at the normal level, then two years at 60% of normal as defaults in commercial mortgages and private credit (including office loans, a disclosed concentration) are realized, a third year at 80%, about 8% dilution from a capital raise at the trough, and a permanently lower level, 95% of normal through year ten and 90% thereafter, with no growth, reflecting continued pension risk transfer price competition and a widening drag from run-off businesses in Corporate & Other (its loss grew from about $295 million in 2023 to about $487 million in 2025). This case is worth about $99 a share. That is well above MetLife's tangible book value of roughly $22 a share, because book value is depressed by about $18 billion of unrealized losses on bonds the company intends to hold to maturity and because the employer benefits franchise, which kept writing business through 2009, is worth more than its capital in a downturn. Bull case: the business grows about 3% a year for a decade, closer to the combined 2023-2025 pace of group benefits, Japan and U.K. longevity reinsurance plus the newly acquired PineBridge fees, and then about 1% a year after that, supported by the employer distribution network that has persisted for decades. This case is worth about $169 a share. What changed since our previous analysis. The September 2026 analysis was built on a different basis that credited ongoing buybacks as additional per-share growth on top of the earnings that fund them; the previous figures are not comparable to these. On the business itself, first-half 2026 results show operating cash flow of $4.9 billion against $6.4 billion a year earlier, while net income rose to $1.9 billion from $1.7 billion, and the share count continued to fall to about 647 million; nothing in the half-year changes our view of the normal earnings level. Margin-of-safety price. We are moderately sure of the earnings level: nine years of results cluster between $4.1 billion and $6.1 billion outside one distorted year, and the group benefits business underneath is steady. The worst plausible event is a severe credit loss in the commercial real estate and private-credit book combined with a run on institutional funding agreements, which could force a capital raise at the bottom as in 2008; the business survived exactly that, but shareholders were diluted. Insurance regulators in each state and country also control how much cash the subsidiaries can send up to the parent, so payouts can be cut in a crisis. If we are wrong about the normal level (closer to $4.1 billion than $4.9 billion) and pension risk transfer keeps eroding, the shares would be worth roughly $110 on a base-style path and well under $90 in a credit cycle. The business pays about $2.40 a share a year in dividends plus buybacks of 4-5% of shares annually while waiting, roughly 7-8% a year at the margin-of-safety price, so the rest of a 20% annual return must come from the price closing toward value over a few years. From $85, the shares are worth about $135 on the median path and near $100 even through a 2008-style cycle; with the dividend and buyback yield and most of that gap closing over an assumed holding period of roughly three years, the base case implies about 20% a year, and the credit-cycle case implies a value still above that price. The margin-of-safety price is $85.